(Bloomberg) -- Early last year, at the onset of the coronavirus pandemic, a small genetics startup called Color Genomics set up a Covid-19 testing lab. It was the first step toward what became a full ...

For $249, Color Genomics wants to tell you if you have the genetic mutations that could predispose you to certain types of cancer. Color launched last April with its breast and ovarian cancer ...